Penumbra is a specialty interventional therapies company that develops and markets innovative medical devices to treat challenging medical conditions with significant unmet clinical needs. We design our therapies to provide our specialist physician customers with improved clinical outcomes through faster and safer procedures at significant overall cost savings to the healthcare system.

Company Growth (employees)
Type
Public
HQ
Alameda, US
Founded
2004
Size (employees)
1,500 (est)
Penumbra was founded in 2004 and is headquartered in Alameda, US

Penumbra Office Locations

Penumbra has offices in Alameda, New York, Jersey, Berlin and in 4 other locations
Alameda, US (HQ)
1351 Harbor Bay Pkwy
Show all (8)

Penumbra Data and Metrics

Penumbra Financial Metrics

Penumbra's revenue was reported to be $73.2 m in Q1, 2017
USD

Revenue (Q1, 2017)

73.2 m

Gross profit (Q1, 2017)

47.7 m

Gross profit margin (Q1, 2017), %

65%

Net income (Q1, 2017)

(3.1 m)

EBIT (Q1, 2017)

(2 m)

Market capitalization (22-Sep-2017)

3 b

Cash (31-Mar-2017)

109.4 m
Penumbra's current market capitalization is $3 b.
USDFY, 2015FY, 2016

Revenue

186.1 m263.3 m

Revenue growth, %

41%

Cost of goods sold

62 m92.5 m

Gross profit

124.1 m170.8 m
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

50.4 m57.9 m65.1 m67.2 m73.2 m

Cost of goods sold

16.9 m18 m23.6 m24.3 m25.5 m

Gross profit

33.5 m39.9 m41.5 m42.9 m47.7 m

Gross profit Margin, %

66%69%64%64%65%
USDFY, 2015FY, 2016

Cash

19.5 m13.2 m

Accounts Receivable

57.2 m47.7 m

Inventories

56.8 m73 m

Current Assets

244.4 m263.8 m
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

159.1 m17.6 m13.9 m15.9 m109.4 m

Inventories

50.3 m66.6 m68.4 m70.1 m79.2 m

Current Assets

249.1 m253.7 m260.3 m267.2 m372.4 m

PP&E

8.6 m9.7 m11.9 m16.2 m22.9 m
USDFY, 2015FY, 2016

Net Income

2.4 m14.8 m

Depreciation and Amortization

1.8 m2.3 m

Accounts Receivable

(11.1 m)(14.6 m)

Inventories

(25.1 m)(19.7 m)
USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

901 k780 k185 k(1.1 m)(3.1 m)

Inventories

50.3 m66.6 m68.4 m70.1 m79.2 m

Accounts Payable

4 m4 m4.1 m3.6 m5 m
USDY, 2017

Revenue/Employee

48.8 k

Financial Leverage

1.1 x
Show all financial metrics

Penumbra Market Value History

Penumbra Job Categories

Traffic Overview of Penumbra

Penumbra News and Updates

This bestselling novelist’s giveaway contest celebrates the beauty of prime numbers

When Robin Sloan wants to give away free copies of his books, he—like most authors—asks fans to participate in a contest. But his contests have…

Neurovascular Devices Market will grow at 4.1% CAGR to surpass 2.3 Billion USD by 2024

Global Neurovascular Devices Market processes include neurothrombectomy, cerebral angiography, coiling, stenting & flow disruption, where coiling procedures segment will lead the overall industry to hit over USD 750 million by 2024. Posted via Industry Today. Follow us on Twitter @IndustryToday

Penumbra Company Life and Culture

You may also be interested in